We have synthesized a series of novel 1-isoindolinone derivatives, which inhibited the contraction of pig coronary artery induced by U-46619, a thromboxane A 2 analog.
Thromboxane A 2 (TXA 2 ) was discovered by Hamberg et al. 2) as a highly unstable and biologically active compound produced from prostaglandin (PG) endoperoxide, which is a potent stimulator of platelet aggregation and mediates vascular and pulmonary smooth muscle contraction.
3) TXA 2 plays an important role in the maintenance of vascular homeostasis together with prostacyclin (PGI 2 ), which has the opposite pharmacological properties.
However, oversynthesis of TXA 2 has been implicated in circulatory disorders and asthmatic conditions. Therefore, TXA 2 receptor antagonists should be clinically useful as therapeutic agents for thrombosis, asthma, ischemia, and myocardial infarction.
4-7)
Recently, we found that some 1-isoindolinone derivatives 8) inhibit TXA 2 analog (U-46619) 9 ) -induced vasoconstriction. Sekiya and Terao 10) have also reported the synthesis of a 3-benzylidene-1-isoindolinone [Chart 1, compound A (RϭH)], which inhibited U-46619-induced vasoconstriction in a screening test. 11) Thus, in order to obtain 3-benzylidene-1-isoindolinone derivatives posessing higher activities, we earlier prepared 3-[(o, m or p)-hydroxy or methoxybenzylidene]-1-isoindolinones (A) and 3-[2-(o, m or p)-hydroxy or methoxyphenylethylidene]-1-isoindolinones (B), 1) as shown in Chart 1. Amongst these compounds, 3-(2-phenylethylidene)-1-isoindolinone derivatives possess higher activities than the 3-benzylidene-1-isoindolinone analogs. Furthermore, 3 
-[2-(o or m)-methoxyphenylethylidene]-1-isoindo-
linone showed the most potent activity. Therefore, in order to synthesize thromboxane receptor antagonists having more potent activities, we have now synthesized compounds (C), in which a hydroxy group or alkyl group is introduced to the isoindolinone skeleton of 3-(2-phenylethylidene)-1-isoindolinone.
Additionally, Hamanaka et. al . reported that compound D shows strong TXA 2 receptor antagonist activity.
12) Thus, we have synthesized N-substituted 3-(2-phenylethylidene)-1-isoindolinone derivatives (compound E) as potentially potent analogs.
In this paper, we have synthesized a variety of 5-or 6-hydroxy-3-(2-phenylethylidene)-1-isoindolinone and N-substituted-3-(2-phenylethylidene)-1-isoindolinone derivatives from 4-hydroxyphthalic acid or potassium phthalimide in several steps and their inhibitory activities tested. First, we describe the synthesis of 5-or 6-hydroxy-3-(2-phenylethylidene)-1-isoindolinone derivatives (6), as shown in Chart 2. 4-Hydroxyphthalic acid (1) was treated with 25% ammonia in a sealed tube at 190°C for 4 h to give 2 in 59% yield. 2 was treated with allyl bromide and K 2 CO 3 in acetone at 70°C for 48 h to afford 4-allyloxyphthalimide (3a) (15%) and N-allyl-4-allyloxyphthalimide (3b) (53%). Subsequently, 3a was reacted with the Grignard reagent (2 eq) prepared from (2-bromoethyl)benzene with Mg in dry tetrahydrofuran (THF), and successive treatment with 3% ammonia and aqueous NH 4 Cl to afford the corresponding alcohol 4a (69%) and 4b (25%). Dehydration of each alcohol with HCl in THF give 5a (99%) and 5b (97%).
The structures of compounds 5a and 5b were confirmed by analyses of their proton nuclear magnetic resonance ( 1 H-NMR), as described in the experimental section. The 1 H-NMR spectra of 5a and 5b showed a characteristic doublet at 3.70-3.72 ppm due to methylene protons with a coupling constant of 8.0 Hz, and triplet at 5.67-5.73 ppm due to methine protons, with a coupling constant of 8.0 Hz. The configuration of the double bond in both 5a and 5b was determined by nuclear Overhauser effect (NOE) experiments. As shown in Chart 2, irradiation of the H-methine of both 5a and 5b clearly enhanced the signal intensities of H-4 in both 5a and 5b. These findings indicated that both compounds have the Z configuration.
Next, in order to introduce a hydroxy and alkyl group to the isoindolinone skeleton of 5, we attempted Claisen rearrangement of 5a and 5b at 180°C for 3 h, according to the literature procedure, 13) however this reaction did not proceed. We then attempted Claisen rearrangement by treatment with BCl 3 in chlorobenzene at Ϫ30°C for 2 h, according to the literature procedure. 14) These reactions resulted only in phenol derivatives 6a (46%) and 6b (66%). Unexpectedly, 6a and 6b showed inhibitory activity against U-46619-induced contraction of pig coronary.
In order to succeed in the Claisen rearrangement process, we protected the NH group of compounds 5a and 5b. 10a and 10b were synthesized from 1 as the starting material. 7 was synthesized with 40% CH 3 NH 2 in a sealed tube at 190°C for 1 h instead of 25% ammonia. Yields were: 7 (59%), 8 (78%), 9a (58%), 9b (14%), 10a (52%) and 10b (81%), respectively. The structures of compounds 10a and 10b were confirmed by analysis of their 1 H-NMR, as described in the experimental section.
The 1 H-NMR spectra of 10a and 10b showed a characteristic doublet at 3.98 ppm due to methylene protons with a coupling constant of 7.7 Hz and a triplet at 5.50-5.56 ppm due to methine protons with a coupling constant of 7.7 Hz. The configuration at the double bond of 10a and 10b was determined by NOE experiments. As shown in Chart 2, irradiation of the H-methine of both 10a and 10b clearly enhanced the signal intensities of the N-CH 3 group in both 10a and 10b. In the same way, irradiation of H-4 of 10a and 10b clearly enhanced the signal intensities of both methylene protons in the side chain of 10a and 10b. These findings indicated that both compounds possess the E configuration for the double bond.
Next, we attempted Claisen rearrangement of 10a and 10b at 180°C for 3 h, but no reaction occurred. Attempted Claisen rearrangement with BCl 3 in chlorobenzene at Ϫ30°C for 2 h only afford 11a (46%) and 11b (85%), which showed biological activity.
We next attempted Claisen rearrangement of 8 as shown in Chart 3. Heating compound 8 at 180°C for 3 h gave 4-allyl-5-hydroxy-N-methylphthalimide (12a) (74%) and 3-allyl-4-hydroxy-N-methylphthalimide (12b) (23%). The structures of these compounds were confirmed by analysis of their 1 H-NMR, as described in the experimental section. The 1 H-NMR spectrum of 12a showed two singlets due to H 4 (7.07 ppm) and H 7 (7.38 ppm), respectively. In the case of 12b, two doublets were present due to H 6 (7.02 ppm) and H 7 (7.47 ppm). 12a and 12b were treated with chloromethylmethyl ether in the presence of N,N-diisopropylethylamine at room temperature for 8 h to afford 13a (100%) and 13b (96%), respectively. 13a reacted with the Grignard reagent (1.5 eq) prepared from (2-bromoethyl)benzene with Mg in dry THF, and successive treatment with 3% NH 3 -NH 4 Cl solution to afford the corresponding alcohol 14a (25%) and 15a (20%). Each alcohol (14a or 15a) reacted with HCl in THF leading to dehydration and removal of the methoxymethyl (MOM) group to give 17a (50%) and 18a (74%). The structures of compounds 17a and 18a were confirmed by analysis of their 1 H-NMR, as described in the experimental section. The 1 H-NMR spectra of 17a and 18a showed a characteristic doublet at 3.96-3.97 ppm due to methylene protons with a coupling constant of 7.9 Hz and a triplet at 5.50-5.52 ppm due to me-thine protons with a coupling constant of 7.9 Hz. The E configuration at the double bond of 17a and 18a was determined by nuclear NOE experiments.
In the same way, 13b reacted with Grignard reagent (1.5 eq) and 3% NH 3 -NH 4 Cl solution to afford the corresponding alcohol 16a (65%) as a single product due to the steric influence of the allyl group. 16a with HCl in THF was dehydrated and the MOM group removed to afford 18b (61%). The structure of compound 18b was confirmed by analysis of 1 H-NMR, as described in the experimental section. The 1 H-NMR spectrum of 18b showed a characteristic doublet at 3.96 ppm due to methylene protons, with a coupling constant of 7.9 Hz, and a triplet at 5.46 ppm, due to methine protons, with a coupling constant of 7.9 Hz. The E configuration at the double bond of 18b was determined by nuclear NOE experiments.
Next, we synthesized 17b, 18c and 18d having a propyl group in the isoindoline moiety. 12c and 12d were synthesized quantitatively by hydrogenation of 12a and 12b with palladium on carbon in ethanol at room temperature for 1 h. By the same route as for 17a, 18a and 18b, compounds (17b, 18c, 18d) were synthesized from 12c and 12d (13c, 93%; 13d, 87%; 14b, 40%; 15b, 16%; 16b, 46%; 17b, 43%; 18c, 74%; 18d, 50%). The structures of compounds 17b, 18c and 18d were confirmed by analysis of their 1 H-NMR, as described in the experimental section. The E configuration of the double bond of 17b, 18c and 18d was determined by NOE experiments, in the same way as for 17a, 18a and 18b.
The inhibitory activity for U-46619-induced vasoconstriction of pig coronary artery was measured for compounds 5a, b, 6a, b, 10a, b, 11a, b, 17a, b, 18a-d . As a result, compounds 5a, b, 10a, b, 17a, b, 18a and 18c showed no activity. As shown in Table 1 , 6a, b, 11a, b, 18b and 18d showed biological activity. In the biological activity, it makes little difference whether these isoindolinone derivatives have a Z or E configuration.
Next, we investigated the synthesis of N-substituted-3-(2-phenylethylidene)isoindolinones. Compounds 22a-c were synthesized according to the reaction sequences in Chart 4. Compounds 20a-c were synthesized by N-alkylation of potassium phthalimide 19 with butyl iodide, hexyl bromide or heptyl bromide in N,N-dimethylformamide (DMF) at 120°C for 2 h according to the literature procedure 15) (20a, 90%; 20b, 31%; 20c, 96%). Subsequently, 20a-c were reacted with the Grignard reagent (2 eq) prepared from (2-bromoethyl)benzene in dry THF to afford the corresponding alcohol, which was used without further purification. Each crude alcohol was treated with 15% aqueous HCl at room temperature to afford 22a (33%), 22b (79%) and 22c (82%), respectively. In the same way, compounds 20d and 20e were synthesized by N-alkylation of potassium phthalimide 19 with N,N-dimethylaminoethyl chloride and g-dimethylaminopropyl chloride (20d, 59%; 20e, 70%). 20d and 20e were reacted with the Grignard reagent, and then with 3% ammonia and NH 4 Cl solution to afford the corresponding alcohols 21d (63%) and 21e (62%). Each alcohol was treated with 15% aqueous HCl for 8 h at room temperature to afford 22d (70%) and 22e (50%), which reacted with methyl iodide in chloroform at room temperature for 8 h to afford 23d (64%) and 23e (89%), respectively.
Compounds 22f-l were synthesized by the same synthetic method as 22a-c (20f, 77%; 20g, 78%; 20h, 82%; 20i, 89%; 20j, 82%; 20k, 86%; 20l, 58%; 22f, 45%; 22g, 67%; 22h, 46%; 22i, 53%; 22j, 27%; 22k, 48%; 22l, 34%). 24i, 25k and 24l were synthesized by treatment with AlBr 3 or BCl 3 in chlorobenzene to afford 24i (27%), 25k (43%) and 24l (55%).
The inhibitory activity for U-46619-induced vasoconstriction of pig coronary artery was measured for compounds  22a-e, 23d, 23e, 22f-i, 24i, 24l, 22j, 22k and 25k . Com-pounds 22a-e, 23d, 23e, 22f-h and 22j showed no activity. As shown in Table 1 , 22i, 24i, 24l, 22k and 25k showed biological activity. The effect of the substituents at the 2-position on the inhibitory activity was approximately in the following order: benzylмphenyl-ethylϾaminoalkylϾalkyl. It is noteworthy that the activities of p-hydroxybenzyl-type and phydroxyphenylethyl-type compounds 24i, 24l, and 25k were inhibitory.
Experimental
Melting points were determined on a micro-melting point apparatus (Yanagimoto) and are uncorrected. IR spectra were taken on JASCO A-202 and JASCO IR-810 infrared spectrophotometers and are given in cm
Ϫ1
. 1 H-NMR spectra were recorded on a JEOL JNM-FX90q (90 MHz) spectrophotometer in CDCl 3 . Chemical shifts are given in d (ppm) downfield from tetramethylsilane, and the abbreviations of signal patterns are as follows: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad. Thin layer chromatography (TLC) was performed on silica gel (Kieselgel 60F 254 on aluminum sheets, Merck). All compounds were located by spraying the TLC plate with sulfuric acid and heating it on a hot plate. Preparative TLC was performed on a preparative layer chromatography plate (Kieselgel 60F 254 2 mm and 0.5 mm, Merck). Column chromatography was performed on silica gel (Kieselgel 60, 70-230 mesh, Merck).
Preparation of 4-Hydroxyphthalimide (2) A solution of 4-hydroxyphthalic acid (1) (4.0 g, 20 mmol) and 25% ammonia (6.0 g, 88 mmol) was heated at 190°C for 4 h in a sealed tube. After the solution had cooled, CHCl 3 was added, and the whole was extracted with CHCl 3 . The CHCl 3 extract was dried over MgSO 4 and concentrated in vacuo. The residue was subjected to column chromatography on SiO 2 using a 10 : 1 mixture of CHCl 3 -MeOH as the eluent to give 2 as a white powder (2.1 g, yield 59 %). 4-hydroxyphthalimide (2): IR (KBr): 3227 (OH), 1758, 1687 (CϭO).
1 H-NMR (CD 3 OD): 7.07 (1H, d), 7.15 (1H, s), 7.63 (1H, d).
Preparation of 4-Hydroxy-N-methylphthalimide (7)
A solution of 4-hydroxyphthalic acid (1) (20 g, 0.11 mol) and 40% methylamine (34 g, 0.44 mol) was heated at 150°C for 1 h and 190°C for 1 h. After the solution had cooled, CHCl 3 was added, and the whole was extracted with CHCl 3 . The CHCl 3 extract was dried over MgSO 4 and concentrated in vacuo. The residue was subjected to column chromatography on SiO 2 using a 10 : 1 mixture of CHCl 3 -MeOH as the eluent to give 7 (2.1 g, Yield 59%). 4-Hydroxy-N-methylphthalimide (7): IR (KBr): 3300 (OH), 1755, 1680 (CϭO). Preparation of 4a, b, 9a, b The Grignard reagent was prepared by the usual method from (2-bromoethyl)benzene (556 mg, 3.0 mmol) and Mg (79 mg, 3.3 mg atom) in dry THF (3 ml). The solution was stirred at 50°C for 1 h, then allowed to cool. 3a (1.5 mmol) or 8 (1.5 mmol) in dry THF (10 ml) was gradually added to this Grignard reagent, then the mixture was stirred for 8 h at room temperature and cooled. Aqueous NH 3 (3%, 10 ml) and NH 4 Cl (10 ml) were added to the reaction mixture at 0°C and the whole was stirred for 30 min at room temperature. The reaction mixture was extracted with CHCl 3 twice and AcOEt. The organic solution was washed with brine, dried over MgSO 4 and concentrated in vacuo. The residue was subjected to column chromatography on SiO 2 using a 1 : 2 mixture of n-hexane-AcOEt as the eluent. In the case of 3a, 5-allyloxy-3-hydroxy-3-phenylethyl-1-isoindolinone (4a) (69%) and 6-allyloxy-3-hydroxy-3-phenylethyl-1-isoindolinone (4b) (25%) were obtained. In the case of 8, 5-allyloxy-3-hydroxy-2-methyl-3-phenylethyl-1-isoindolinone (9a) (58%) and 6-allyloxy-3-hydroxy-2-methyl-3-phenylethyl-1-isoindolinone (9b) (14%), were obtained.
Preparation of 5a, b, 10a, b Conc. HCl (3 or 4 drops) was added to a solution of 4a, 4b, 9a or 9b (0.4 mmol) in THF (15 ml) at 0°C and the whole was stirred for 8 h at room temperature. The reaction mixture was extracted with CHCl 3 twice and AcOEt. The organic solution was washed with brine, dried over MgSO 4 and concentrated in vacuo. The residue was subjected to column chromatography on SiO 2 using a 1 : 1 mixture of n-hexaneAcOEt as the eluent to give 5a (99%), 5b (97%), 10a (52%) and 10b (81%), respectively. 5-Allyloxy Preparation of 6a, b,11a, b BCl 3 (0.52 mmol) in chlorobenzene (3 ml) was added to a solution of 5a, 5b, 10a or 10b (0.52 mmol) in chlorobenzene (3 ml) at Ϫ30°C, and the mixture stirred at Ϫ30°C for 2 h. CH 3 OH was added, and the whole was washed with brine. The solution was extracted with CHCl 3 twice and CH 3 COOEt. The extract was dried over MgSO 4 and concentrated in vacuo. The resulting residues were subjected to column chromatography on SiO 2 using a 1 : 2 mixture of n-hexane-AcOEt as the eluent to give 6a (46%), 6b (66%), 11a (46%), and 11b (85%), respectively. Pig coronary artery was carefully isolated from fresh adult pig heart, and muscle strips approximately 2 mm wide and 10 mm long were prepared. Each strip was mounted in an organ bath filled with 10 ml of Tyrode's solution (158.3 mM NaCl, 4.0 mM KCl, 2.0 mM CaCl 2 , 1.1 mM MgCl 2 , 10.0 mM NaHCO 3 , 0.4 mM NaH 2 PO 4 , and 5.6 mM glucose), maintained under a tension of 1.5 g at 37°C and bubbled with a 95% O 2 -5% CO 2 gas mixture. Isometric tension was measured with a force displacement transducer and pen-writing recorder (TB-612T, WI-641G, Nihon Kohden).
The activity is expressed as the concentration caused 50% inhibition (IC 50 ) of U-46619-induced vascontraction. 1H, d) .
N-methylphthalimide (12b): IR (neat): 3259 (OH), 1756, 1682 (CϭO
Preparation of 13a-d N,N-Diisopropylethylamine (646 mg, 5 mmol) was gradually added to a solution of 12 (3.3 mmol) in dry dichloromethane (15 ml). Chloromethyl methyl ether (317 mg, 4 mmol) was then gradually added. The mixture was stirred for 1 h at 0°C and for 8 h at room temperature. The reaction mixture was extracted with CHCl 3 twice. The organic solution was washed with brine, dried over MgSO 4 and concentrated in vacuo. The residue was subjected to column chromatography on SiO 2 using a 1 : 1 mixture of n-hexane-AcOEt as the eluent to afford 13. Reaction of Grignard Reagent with 13a-d 13a-d were reacted with Grignard reagent by the same procedure as for 3a and 3b. 13a gave 6-allyl-3-hydroxy-2-methyl-5-methoxymetholoxy-3-phenylethyl-1-isoindolinone (14a) (25%) and 5-allyl-3-hydroxy-2-methyl-6-methoxymethyloxy-3-phenylethyl-1-isoindolinone (15a) (20%). 13b gave 7-allyl-3-hydroxy-2-methyl-6-methoxymethyloxy-3-phenylethyl-1-isoindolinone (16a) (65%). 13c gave 3-hydroxy-2-methyl-5-methoxymethyl-3-phenylethyl-6-propyl-1-isoindolinone (14b) (40%) and 3-hydroxy-2-methyl-6-methoxymethyl-3-phenylethyl-5-propyl-1-isoindolinone (15b) (16%). 13d gave 3-hydroxy-2-methyl-6-methoxymethyloxy-3-phenylethyl-7-propyl-1-isoindolinone (16b) (46%).
Preparation of 17a, b and 18a-d Conc. HCl (3 or 4 drops) was added to a solution of 14a, 14b, 15a, 15b, 16a or 16b (0.8 mmol) in THF (15 ml) at 0°C and the whole was stirred for 8 h at room temperature. The reaction mixture was extracted with CHCl 3 twice and AcOEt. The organic solution was washed with brine, dried over MgSO 4 and concentrated in vacuo. The residues were subjected to column chromatography on SiO 2 using a 1 : 2 mixture of n-hexane-AcOEt as eluent to give 17a (50%), 17b (43%), 18a (74%), 18c (74%), 18b (61%), and 18d (50%), respectively. 6-Allyl-5-hydroxy-2-methyl-3-[(E) 
